基于高血压炎症反应探讨高血压治疗研究进展

Research progress of hypertension treatment based on hypertensive inflammatory response

高血压是血管炎症的概念已被广泛认同,并已进行了大量相关实验,但在临床应用上尚未取得突破性进展。现临床治疗高血压的药物仍基于以往高血压发病机制,对高血压的治疗未取得满意效果。本文从高血压与炎症反应的相互关系展开,综述近3年中西医治疗高血压与炎症反应的相关研究,以期为高血压防治提供新的方向与靶点,从而更好地控制高血压,减少其靶器官损害。

The concept that hypertension is vascular inflammation has been widely recognized.A large number of experiments have been carried out in the past,but no relevant breakthroughs have been made in clinical application.At present,the drugs for clinical treatment of hypertension still take the previous pathogenesis of hypertension as the target,so the treatment of hypertension has not achieved satisfactory results.This article starts from the relationship between hypertension and inflammatory response,and integrates relevant research on the treatment of hypertension and inflammatory response by Chinese and Western medicine in the past three years,with a view to providing new directions and targets for the prevention and treatment of hypertension,so as to better control hypertension and target organ damage.